SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-009092
Filing Date
2020-05-15
Accepted
2020-05-15 16:06:44
Documents
60
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 622928
2 ex10-8.htm EX-10.8 32291
3 ex31-1.htm EX-31.1 19604
4 ex31-2.htm EX-31.2 20291
5 ex32-1.htm EX-32.1 10913
  Complete submission text file 0001493152-20-009092.txt   4225495

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE aker-20200331.xml EX-101.INS 637180
7 XBRL SCHEMA FILE aker-20200331.xsd EX-101.SCH 80568
8 XBRL CALCULATION FILE aker-20200331_cal.xml EX-101.CAL 57389
9 XBRL DEFINITION FILE aker-20200331_def.xml EX-101.DEF 201293
10 XBRL LABEL FILE aker-20200331_lab.xml EX-101.LAB 493520
11 XBRL PRESENTATION FILE aker-20200331_pre.xml EX-101.PRE 291363
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36268 | Film No.: 20885053
SIC: 2835 In Vitro & In Vivo Diagnostic Substances